echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > 30 billion Chinese herbal formula granules market gradually opens up the layout of multiple pharmaceutical enterprises

    30 billion Chinese herbal formula granules market gradually opens up the layout of multiple pharmaceutical enterprises

    • Last Update: 2017-09-28
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    [market analysis of China Pharmaceutical network] the market of traditional Chinese medicine formula granules has grown rapidly In 2015, the total market value of domestic traditional Chinese medicine formula granules reached 8 billion yuan, and the annual compound growth rate reached 40% The current national sales of traditional Chinese medicine formula granules Market is between 8 billion -100 billion yuan It is expected that by 2020, the total market value will reach 30 billion yuan Facing the gradually open market, many pharmaceutical companies hope to take a share On September 26, Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd received the reply from Guangdong food and Drug Administration and agreed to carry out the pilot study of traditional Chinese medicine formula granules in the province according to the standard Before the 30 billion market was gradually opened up in Baiyunshan, Guangzhou, two pharmaceutical companies in Guangdong Province had carried out pilot research on Herbal Pieces formula granules At the end of June, Kangmei Pharmaceutical Co., Ltd obtained the pilot of traditional Chinese medicine formula granules in Guangdong Province In late August, Xiangxue Pharmaceutical Co., Ltd received the approval of Guangdong food and Drug Administration for the company to carry out the pilot study of traditional Chinese medicine formula granules in Guangdong Province according to the standard There are more than 600 enterprises with GMP certificate and granule production capacity and TCM extraction and processing capacity in China Only from the perspective of Guangdong market, the main enterprises are China Resources Sanjiu and one party pharmaceutical: in 2016, the sales of formula granules of China Resources Sanjiu was about 1.5 billion, and that of one party pharmaceutical was about 1.6 billion The market of traditional Chinese medicine formula granules is growing rapidly In 2015, the total market value of traditional Chinese medicine formula granules reached 8 billion yuan, with an annual compound growth rate of 40% The current national sales of traditional Chinese medicine formula granules are between 8 billion yuan and 10 billion yuan It is estimated that by 2020, the market value will reach 30 billion yuan However, subject to regulatory approval, the industry is highly intensive, and the market share of 10 billion yuan has long been controlled by six approved pilot production enterprises Since 2002-2004, only Jiangyin Tianjiang Pharmaceutical Co., Ltd., China Resources Sanjiu, Beijing kangrentang Pharmaceutical Co., Ltd (later merged by HongRi Pharmaceutical Co., Ltd.), Peili (Nanning) Pharmaceutical Co., Ltd., Sichuan new green Pharmaceutical Co., Ltd and Guangdong Yifang Pharmaceutical Co., Ltd (later merged by Tianjiang Pharmaceutical Co., Ltd.) have passed the CFDA record review and received the approval of the pilot production enterprises The state has been cautious about the development of traditional Chinese medicine formula granules In July 2001, CFDA issued the Interim Provisions on the management of traditional Chinese medicine formula granules, which clearly included the traditional Chinese medicine formula granules in the management of herbal pieces This policy was not loosened until 2015 At the end of 2015, CFDA issued the management measures for granules of traditional Chinese medicine (Draft for comments) and the technical requirements for quality control and standard setting of granules of traditional Chinese medicine (Draft for comments) It was proposed that the pilot restrictions on granules of traditional Chinese medicine would be released The enterprises of traditional Chinese medicine production only need to be approved by the local provincial food and Drug Administration and perform relevant procedures Sequence can be produced After the opinion draft came out, the whole industry was quickly ignited Many listed companies have laid out this field, waiting for the market to open up and share a piece of the cake The approval document of Kangmei pharmaceutical industry took 10 days is an example At the same time, we still need to be careful from the beginning of the birth of traditional Chinese medicine formula granules, and the dispute about its efficacy and quality has not been stopped In addition to the characteristics of effective application and convenient use, and the advantages of policies such as not included in centralized procurement, 25% addition according to Chinese herbal pieces, not included in the proportion of drugs in public hospitals, etc., make Chinese herbal formula granules popular in the market However, compared with Chinese herbal pieces, the composition of Chinese herbal formula granules is complex Each Chinese herbal medicine has huge differences in the standards of raw material quality control, production process, process control, terminal quality control or quality inspection, almost all links There has been controversy on how to form a unified industry standard According to the relevant survey results, nearly 90% of doctors said that the main reason for choosing traditional Chinese medicine formula granules is convenient and fast, but in terms of curative effect, nearly 60% of doctors are reluctant to use it because of "uncertain curative effect of traditional Chinese medicine formula granules" Because of the long-term dispute in the field of traditional Chinese medicine formulation granules Guangdong Province has set up a threshold for enterprises to carry out pilot research and production of TCM formula granules On June 19, 2015, Guangdong Province issued the "Application guide for pilot production of traditional Chinese medicine formula granules in Guangdong Province" According to the requirements, manufacturers should carry out pilot production of traditional Chinese medicine formula granules in Guangdong Province according to the "standard of traditional Chinese medicine formula granules in Guangdong Province" and the 203 varieties of traditional Chinese medicine formula granules in Volume II In the face of not low threshold, it is estimated that not many manufacturers can meet the requirements If the entry threshold is too low, the consequences may be similar to that of Chinese herbal pieces, "small, scattered, disorderly, and regulatory trouble", which is not conducive to the healthy development of the industry Original title: many pharmaceutical companies carry out pilot research on traditional Chinese medicine formula granules, teach you to use app (Pharma) in the whole process, seize the opportunity of pharmaceutical machinery
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.